Posted inMarket
MPM BioVentures 2018 Disposes of Entrada Therapeutics Shares Worth $617k
Explore the recent financial transaction involving MPM BioVentures 2018 selling $617,000 worth of Entrada Therapeutics shares in the market.
Posted inMarket
MPM BioVentures Executes Significant Share Sale in Entrada Therapeutics
Discover the latest insider trading activity as major shareholder MPM BioVentures sells over six hundred thousand dollars in Entrada Therapeutics stock.
